LEI 529900OAREIS0MOPTW25

MERCK Kommanditgesellschaft auf Aktien

Group parent: E. Merck KG

Awards tracked

44

Value

€10.2M

Countries

DE

Download sample CSV

Contract awards & public grants

FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2026-06-02

—

STewardship and Recognition for DAta Science Talent → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2026-04-27

€206,250

SynCellEU programme for recruiting next generation European leaders in Synthetic Cell research → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2026-02-20

—

Breakthrough Regulatory Innovation and Development throuGh sandbox Environments → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2025-11-07

—

101219311 - BRIDGE - BREAKTHROUGH REGULATORY INNOVATION AND DEVELOPMENT THROUGH SANDBOX ENVIRONMENTS → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

IMI - Innov.Health Initiative · DE · Grant · 2025-11-01

€5.2M

Advancing Safe and Sustainable by design Practices in Pharmaceutical Manufacturing → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2024-12-05

—

Reducing Non-Human Primates in Non-Clinical Safety Assessment: The European Initiative on Minipig and Micropig Models → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2024-11-12

—

Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2024-07-26

—

101140006 - ECDA - EUROPEAN CHIPS DIVERSITY ALLIANCE → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

EACEA - Education, Audiovisual and Culture Executive Agency · DE · Grant · 2024-04-01

€87,947

- addressing the challenges of high-performance solution-processed OLEDs using sustainable materials → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2022-06-20

—

BEhavioral and Adherence Model for improving quality, health outcomes and cost-Effectiveness of healthcaRe → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2021-09-27

—

Real World Handling of Protein Drugs - Exploration, Evaluation and Education → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2021-07-05

—

Building a reproducible single-cell experimental workflow to capture tumour cell persistence → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2021-06-28

—

Innovative high-value cosmetic products from plants and plant cells → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2021-05-03

€70,988

Establishing international standards in the analysis of patient reported outcomes and health-related quality of life data in cancer clinical trials → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2020-11-09

—

HIGH PERFORMING AND SAFE SOLVENT DERIVED FROM CELLULOSIC FEEDSTOCKS → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2020-09-21

€100,615

Corona Accelerated R&D in Europe → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2020-08-07

—

Immune Safety Avatar: nonclinical mimicking of the immune system effects of immunomodulatory therapies → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2019-11-18

—

Trials@Home: Center of Excellence – Remote Decentralised Clinical Trials → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2019-08-07

—

MachinE Learning Ledger Orchestration for Drug DiscoverY → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2019-05-22

—

Building an ecosystem for better monitoring and communicating of medication safety in pregnancy and breastfeeding: validated and regulatory endorsed w → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2019-05-06

—

Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2019-04-23

—

Connecting digital mobility assessment to clinical outcomes for regulatory and clinical endorsement → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2019-03-22

—

European Screening Centre; Unique Library for Attractive Biology → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2018-12-18

—

Using the smart matrix approach to enhance TADF-OLED efficiency and lifetime → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2018-08-21

€252,788

Appearance Printing - European Advanced Research School → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2018-08-20

—

Chemical Engineering Immersive Learning → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2018-08-20

€252,788

Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medici → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2018-06-04

—

Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2017-09-12

—

Computational ONcology TRaining Alliance → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2017-08-31

—

European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2017-08-17

—

Big Data for Better Outcomes, Policy Innovation and Healthcare System Transformation - Sofia ref.: 116055 → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2017-01-30

—

Patient Preferences in benefit risk assessments during the drug life cycle - Sofia ref.: 115966 → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2016-10-21

—

Development of high-performance, hyperfluorescence OLEDs for use in display applications and solid state lighting → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2016-10-12

€1.47M

Continuous Resolution and Deracemization of Chiral Compounds by Crystallization → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2016-08-31

—

Targeting SYNthetic lethal interactions for new cancer treatments TRAINing network → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2016-08-10

—

Pharmaceutical Education And Research with Regulatory Links: Innovative drug development strategies and regulatory tools tailored to facilitate earlie → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2016-02-12

€249,216

Production technology to achieve low Cost and Highly Efficient phOtovoltaic Perovskite Solar cells → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2015-11-30

€501,354

Accelerated Development of Appropriate Patient Therapies: a Sustainable, Multi-stakeholder Approach from Research to Treatment-outcomes - Sofia ref.: → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2015-09-02

—

Donor-Acceptor light emitting exciplexes as materials for easily to tailor ultra-efficient OLED lighting → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2015-07-31

—

Interfaces in opto-electronic thin film multilayer devices → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2015-07-28

—

EMBL Interdisciplinary, International and Intersectorial Postdocs → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2015-05-13

—

Sustainable downstream processing of vaccines through incorporation of nanobiotechnologies : novel affinity ligands and biomimetic membranes → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2015-02-11

€1.4M

Advanced high-resolution printing of organic Transistors for Large Area Smart Surfaces → MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN

European Commission · DE · Grant · 2014-12-15

€405,860

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.